As of January 22, 2025, BeyondSpring (BYSI) has a market cap of $70.526 million USD. According to our data, BeyondSpring is ranked No.7951 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $70.53 M |
7.36%
|
Dec 31, 2024 | $65.69 M |
81.11%
|
Dec 29, 2023 | $36.27 M |
-52.13%
|
Dec 30, 2022 | $75.76 M |
-58.50%
|
Dec 31, 2021 | $0.18 B |
-62.87%
|
Dec 31, 2020 | $0.49 B |
-21.29%
|
Dec 31, 2019 | $0.62 B |
-17.33%
|
Dec 31, 2018 | $0.76 B |
-35.52%
|
Dec 29, 2017 | $1.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Market Cap | = | BYSI Stock Price | * | BYSI Shares Outstanding |
= | $1.75 | * | 40.30 M | |
= | $70.53 M |